457 related articles for article (PubMed ID: 14733708)
1. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
[TBL] [Abstract][Full Text] [Related]
2. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.
Sharif NA; Kelly CR; Crider JY
J Ocul Pharmacol Ther; 2002 Aug; 18(4):313-24. PubMed ID: 12222762
[TBL] [Abstract][Full Text] [Related]
3. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.
Sharif NA; Kelly CR; Crider JY
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):715-21. PubMed ID: 12556403
[TBL] [Abstract][Full Text] [Related]
4. Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors.
Kelly CR; Williams GW; Sharif NA
J Pharmacol Exp Ther; 2003 Jan; 304(1):238-45. PubMed ID: 12490597
[TBL] [Abstract][Full Text] [Related]
5. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
Ota T; Aihara M; Narumiya S; Araie M
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494
[TBL] [Abstract][Full Text] [Related]
6. Cat iris sphincter smooth-muscle contraction: comparison of FP-class prostaglandin analog agonist activities.
Sharif NA; Kaddour-Djebbar I; Abdel-Latif AA
J Ocul Pharmacol Ther; 2008 Apr; 24(2):152-63. PubMed ID: 18355130
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeys.
Gabelt BT; Hennes EA; Bendel MA; Constant CE; Okka M; Kaufman PL
J Ocul Pharmacol Ther; 2009 Feb; 25(1):1-8. PubMed ID: 19232013
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the involvement of cannabinoid CB1 receptors in the bimatoprost-induced contractions on the human isolated ciliary muscle.
Romano MR; Lograno MD
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3677-82. PubMed ID: 17652738
[TBL] [Abstract][Full Text] [Related]
9. Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes.
Sharif NA; Williams GW; Crider JY; Xu SX; Davis TL
J Ocul Pharmacol Ther; 2004 Dec; 20(6):489-508. PubMed ID: 15684809
[TBL] [Abstract][Full Text] [Related]
10. Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist.
Hellberg MR; Sallee VL; McLaughlin MA; Sharif NA; Desantis L; Dean TR; Zinke PW
J Ocul Pharmacol Ther; 2001 Oct; 17(5):421-32. PubMed ID: 11765147
[TBL] [Abstract][Full Text] [Related]
11. Synthetic FP-prostaglandin-induced contraction of rat uterus smooth muscle in vitro.
Sharif NA
Prostaglandins Leukot Essent Fatty Acids; 2008 Mar; 78(3):199-207. PubMed ID: 18375109
[TBL] [Abstract][Full Text] [Related]
12. Preclinical pharmacology of AL-12182, a new ocular hypotensive 11-oxa prostaglandin analog.
Sharif NA; McLaughlin MA; Kelly CR; Xu S; Crider JY; Williams GW; Parker JL
J Ocul Pharmacol Ther; 2006 Oct; 22(5):291-309. PubMed ID: 17076623
[TBL] [Abstract][Full Text] [Related]
13. Human ciliary muscle cell responses to FP-class prostaglandin analogs: phosphoinositide hydrolysis, intracellular Ca2+ mobilization and MAP kinase activation.
Sharif NA; Crider JY; Husain S; Kaddour-Djebbar I; Ansari HR; Abdel-Latif AA
J Ocul Pharmacol Ther; 2003 Oct; 19(5):437-55. PubMed ID: 14583136
[TBL] [Abstract][Full Text] [Related]
14. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
Bhattacherjee P; Williams BS; Paterson CA
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
[TBL] [Abstract][Full Text] [Related]
15. Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques.
Sharif NA; Davis TL
J Pharm Pharmacol; 2002 Apr; 54(4):539-47. PubMed ID: 11999132
[TBL] [Abstract][Full Text] [Related]
16. AL-3138 antagonizes FP prostanoid receptor-mediated inositol phosphates generation: comparison with some purported FP antagonists.
Sharif NA; Crider JY; Davis TL
J Pharm Pharmacol; 2000 Dec; 52(12):1529-39. PubMed ID: 11197083
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle.
Krauss AH; Wiederholt M; Sturm A; Woodward DF
Exp Eye Res; 1997 Mar; 64(3):447-53. PubMed ID: 9196397
[TBL] [Abstract][Full Text] [Related]
18. Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
Woodward DF; Krauss AH; Chen J; Gil DW; Kedzie KM; Protzman CE; Shi L; Chen R; Krauss HA; Bogardus A; Dinh HT; Wheeler LA; Andrews SW; Burk RM; Gac T; Roof MB; Garst ME; Kaplan LJ; Sachs G; Pierce KL; Regan JW; Ross RA; Chan MF
Br J Pharmacol; 2000 Aug; 130(8):1933-43. PubMed ID: 10952685
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
Ota T; Murata H; Sugimoto E; Aihara M; Araie M
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization.
Griffin BW; Magnino PE; Pang IH; Sharif NA
J Pharmacol Exp Ther; 1998 Jul; 286(1):411-8. PubMed ID: 9655886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
